To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
At Karmanos, we believe in care beyond medicine and stand united with the community in the fight against cancer. Our monthly newsletter, ‘Caring. Healing. Informing.’ is an essential part of this commitment. Patients, families, caregivers, friends, and community members in the 46 counties we serve are connected by this newsletter – a beacon of hope and knowledge. From new, industry-leading cancer treatments to inspiring stories of resilience from our patients, including groundbreaking updates in research and care and information about special events, you’ll feel part of Team Karmanos. Stand with us and sign up to receive ‘Caring. Healing. Informing.’ and be part of our story.
WJR The new U.S. Preventative Services Task Force recommendations state that women should receive mammograms every other year starting at 40. Howe...
A fourth-year doctoral student in the Cancer Biology Graduate Program at the Wayne State University School of Medicine and the Barbara Ann Karmano...
Skin cancer is the most common form of cancer. The type of skin cancer someone has can impact both their prognosis and treatment options. There ar...